Anzeige
Mehr »
Login
Montag, 20.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
180 Leser
Artikel bewerten:
(1)

The Business Research Company: Hospital Acquired Infections Testing Kits Market Research Shows Growth At 13% Rate With Increasing Disease Susceptibility

Finanznachrichten News

TBRC's global hospital acquired infections testing kits market report goes over the various drivers which will lead to the market size reaching $1.8 Bn by 2026.

LONDON, April 7, 2022 /PRNewswire/ -- The hospital acquired infections testing kits market is expected to be driven by increased incidence rates of chronic diseases. The hospital acquired infection rates are higher among patients with increased susceptibility because of old age and underlying chronic diseases, such as COVID-19.

tbrc_logo

The global hospital acquired infections testing kits market size is expected to grow from $1.12 billion in 2021 to $1.27 billion in 2022 at a compound annual growth rate (CAGR) of 12.7%. The global hospital acquired infection testing kit market is expected to grow to $1.78 billion in 2026 at a CAGR of 8.8%.

Request a free sample of the Market Report

Regional Outlook Of The Hospital Acquired Infections Testing Kits Marke

North America has the largest hospital acquired infections testing kits market share, accounting for 36.2% of the total in 2021. It was followed by Asia-Pacific, and then the other regions. Going forward, the fastest-growing regions in the hospital acquired infections testing kits market will be South America, Africa and, Middle East where growth will be at CAGRs of 9.3%, 8.8% and 8.8% respectively. These will be followed by Asia Pacific, and Western Europe.

Rise in Healthcare Expenditure To Drive The Growth Of The Hospital Acquired Infections Testing Kits Marke

Increasing healthcare expenditure is predicted to upsurge the demand for the hospital acquired infections testing kits market. The growth in healthcare expenditure is aiding governments and organizations to spend more on prescription drugs, hospitals, and physical & clinical services, thereby driving the hospital acquired infections testing kits market. According to the National Health Expenditure Projections for 2018-2027, national healthcare expenditure is expected to reach nearly $6.0 trillion by 2027 in the USA, growing at an average rate of 5.5% annually from 2018 to 2027. Consequently, as per TBRC's hospital acquired infections testing kits industry growth analysis, the rise in healthcare spending will increase the demand for hospital acquired infections testing kits in the near future.

COVID-19 Impact On The Market

The unprecedented outbreak of coronavirus has caused a surge in demand for hospital acquired infections testing kits, due to the rise in hospital acquired infections during the pandemic. The pandemic has raised enormous quality of care concerns in hospitals, due to the rising number of patients during COVID-19 and the change in staffing numbers. Multiple hospitals have experienced an increase in staffing levels, with traveling nurses reporting that these nurses were unfamiliar with hospital's infection control processes. Such circumstances made it difficult for hospitals to maintain patient safety and quality of care. According to a U.S. Department of Health and Human Services report, one hospital in the US experienced an increase in central line infections during COVID-19, including life-threatening infections. COVID-19 patients usually experienced a lengthy stay in hospitals, making them more prone to hospital acquired infections.

See more on the Market Report

Check out similar market reports:

COVID-19 Rapid Test Kits Market 2022 - By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Kit Type (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Blood), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care), And By Region, Opportunities And Strategies - Global Forecast To 2030

Hospital Supplies Global Market Report 2022 - By Type (Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) - Market Size, Trends, And Global Forecast 2022-2026

Hospitals And Outpatient Care Centers Global Market Report 2022 - By Type (Hospitals, Outpatient Care Centers), By End User Gender (Male, Female), By Type of Expenditure (Public, Private) - Market Size, Trends, And Global Forecast 2022-2026

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has strategy enablement specialists in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Logo: https://mma.prnewswire.com/media/1751581/tbrc_logo.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.